Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioMarin Pharmaceutical Inc. buy Sanford C. Bernstein

Start price
€85.64
20.08.24 / 50%
Target price
€99.09
20.08.25
Performance (%)
-1.52%
Price
€84.34
20.08.24
Summary
This prediction is currently active. With a performance of -1.52%, the BUY prediction for BioMarin Pharmaceutical Inc. by Sanford_C__Bernstein is down slightly. This prediction currently runs until 20.08.25. The prediction end date can be changed by Sanford_C__Bernstein at any time. Sanford_C__Bernstein has 50% into this prediction
Performance without dividends (%)
Name 1w
BioMarin Pharmaceutical Inc. -1.52%
iShares Core DAX® 3.126%
iShares Nasdaq 100 3.003%
iShares Nikkei 225® 4.991%
iShares S&P 500 1.852%

Comments by Sanford_C__Bernstein for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -1.52%
Target price 99.088
Change
Ends at 20.08.25

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating. They now have a $110.00 price target on the stock, up previously from $94.00.
Ratings data for BMRN provided by MarketBeat